BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aprile G, Fontanella C, Lutrino ES, Ferrari L, Casagrande M, Cardellino GG, Rosati G, Fasola G. Angiogenic inhibitors for older patients with advanced colorectal cancer: Does the age hold the stage? World J Gastroenterol 2013; 19(14): 2131-2140 [PMID: 23847406 DOI: 10.3748/wjg.v19.i14.2131]
URL: https://www.wjgnet.com/1007-9327/full/v19/i14/2131.htm
Number Citing Articles
1
Carmine Pinto, Lorenzo Antonuzzo, Luca Porcu, Giuseppe Aprile, Evaristo Maiello, Gianluca Masi, Fausto Petrelli, Mario Scartozzi, Valter Torri, Sandro Barni. Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisClinical Colorectal Cancer 2017; 16(2): e61 doi: 10.1016/j.clcc.2016.08.006
2
Xiaoqiang Zhu, Xianglong Tian, Chenyang Yu, Jie Hong, Jingyuan Fang, Haoyan Chen. Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumabMedicine 2016; 95(34): e4232 doi: 10.1097/MD.0000000000004232
3
Ciara M. Kelly, Derek G. Power, Stuart M. Lichtman. Targeted Therapy in Older Patients With Solid TumorsJournal of Clinical Oncology 2014; 32(24): 2635 doi: 10.1200/JCO.2014.55.4246
4
Gerardo Rosati, Giuseppe Aprile, Elena Poletto, Antonio Avallone. An update on the management of metastatic colorectal cancer in the elderlyColorectal Cancer 2014; 3(5): 451 doi: 10.2217/crc.14.32